Skip to content
Xinzhiyuan · WeChat

MoleculeMind releases MMDesign, claims over 90% target hit rate

超越国际顶尖模型!分子之心推MMDesign,靶点命中率狂飙至90%

MoleculeMind released MMDesign, an AI platform for de novo biologics design. In tests across 12 therapeutic targets, it validated specific binding on 11 targets, sending only 14 to 50 molecules per target into wet-lab assays and reporting a target success rate above 90%.

Why it matters: MoleculeMind's MMDesign platform ran wet-lab tests on 14 to 50 molecules per target across 12 therapeutic targets, with specific binding measured on 11 of them.

Read the original ↗Export Markdown